-
Background: The study investigated genetic and epigenetic alterations, including TERT structural rearrangements and promoter methylation status, in metastatic pheochromocytomas to identify molecular markers associated with malignancy and disease progression.
-
Key Finding: Utilizing Methylation-Sensitive High-Resolution Melting (MS-HRM) analysis, the researchers demonstrated specific epigenetic and structural alterations within the TERT promoter region, correlating these findings with aggressive disease phenotypes.
-
Conclusion: MS-HRM methodology proved effective for evaluating TERT promoter changes, supporting the utility of targeted epigenetic analysis in understanding metastatic neuroendocrine tumors.
-
Original Article & Authors: Published in Endocrine-Related Cancer (2018) by Daniel Gillett, Azita Monazzam, Luigi Aloj, Per Hellman, Hanna Wargelius, and colleagues from Uppsala University and Akademiska Sjukhuset, Uppsala, Sweden.
For to read the full publication, see the link below ↓
